A Multicentre Phase IIb Trial to Evaluate the Efficacy and Tolerability of ModraDoc006/r in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC), Suitable for Treatment With a Taxane

IRB/UVA Tracking #
21771
Contact
Contact Phone
Phase
II
Primary purpose
Treatment
Cancer PI
Robert Dreicer
Status
OPEN TO ACCRUAL
Ages
Adult